OA 09.06 A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLCJin‐Ji Yang, Yi‐Long Wu, C.Z. Zhou et al.|Journal of Thoracic Oncology|2017Cited by 18